Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Rapamycin is active against B-precursor leukemia <i>in vitro</i> and <i>in vivo</i> , an effect that is modulated by IL-7-mediated signaling

Rapamycin is active against B-precursor leukemia in vitro and in vivo , an effect... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Proceedings of the National Academy of Sciences Unpaywall

Rapamycin is active against B-precursor leukemia <i>in vitro</i> and <i>in vivo</i> , an effect that is modulated by IL-7-mediated signaling

Proceedings of the National Academy of SciencesDec 1, 2003
Loading next page...
 
/lp/unpaywall/rapamycin-is-active-against-b-precursor-leukemia-i-in-vitro-i-and-i-in-0u2m2WiNqy

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Unpaywall
ISSN
0027-8424
DOI
10.1073/pnas.2436348100
Publisher site
See Article on Publisher Site

Abstract

Journal

Proceedings of the National Academy of SciencesUnpaywall

Published: Dec 1, 2003

There are no references for this article.